Chimborazo Capital is an independent equity research platform.
I publish my investment theses to refine process, document conviction, and build a public track record. Each idea combines bottom-up observation, fundamental data, sentimental context, and technical triggers.
Receive update notifications: https://chimborazocapital.beehiiv.com/
2025 Q2 Report released on 7/7/25
Read the introduction letter here
| Ticker | Direction | Avg Fill | Date Entry | Exit Price | Date Exit | Return | Thesis Link |
|---|---|---|---|---|---|---|---|
| DAL | Long | $46.08 | 6/13/25 | TBD | TBD | TBD | [Read] |
| TSLA | Long | $284.31 | 6/5/25 | TBD | TBD | TBD | [Read] |
| UNH | Long | $319.55 | 4/17/25 | TBD | TBD | TBD | [Read] |
| NVDA | Long | $101.27 | 4/3/25 | $141.38 | 5/29/25 | +39% | [Read] |
| AFRM | Long | $37.31 | 3/20/25 | TBD | TBD | TBD | [Read] |
| PLTR | Long | $76.37 | 2/27/25 | $112.03 | 4/25/25 | +46% | [Read] |
| TSLA | Long | $240.67 | 2/26/25 | $366.30 | 4/22/25 | +52% | [Read] |
| LMT | Long | $444.11 | 1/28/25 | TBD | TBD | TBD | [Read] |
| NVDA | Long | $118.25 | 1/27/25 | $142.14 | 2/18/25 | +20% | [Read] |
| CELH | Long | $27.33 | 10/1/24 | $40.32 | 6/4/25 | +49% | [Read] |